| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8447550 | European Journal of Cancer | 2011 | 10 Pages |
Abstract
MRD detection measured by a panel of NB specific-PCR targets could identify fast responders, who clear their BM early during treatment. Fast molecular response was a prognostic factor, associated with better outcome. Our data indicate that MRD analysis during induction therapy should be included in prospective MRD studies.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
J. Stutterheim, L. Zappeij-Kannegieter, R. Versteeg, H.N. Caron, C.E. van der Schoot, G.A.M. Tytgat,